Hospira Announces New Contract With MedAssets for Intravenous Solutions, Renewal of Infusion Devices...( LAKE FOREST Ill. June 30 /- Hospira I...)

LAKE FOREST, Ill., June 30 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced agreements with MedAssets on intravenous (I.V.) solutions and gravity I.V. equipment, and a renewal of its agreement for infusion devices. The five-year MedAssets agreements are effective as of June 1, 2009, for I.V. solutions and equipment, and July 1, 2009, for infusion devices. These new agreements represent a first for Hospira from a contract award position on I.V. solutions and gravity I.V. equipment.

"MedAssets shares Hospira's commitment to improving patient and healthcare safety, as well as finding ways to reduce the high costs of healthcare," said Pete Baker, vice president and general manager, Commercial Service Operations, Hospira. "We look forward to continuing our work with MedAssets' member healthcare institutions to drive these goals."

The agreements, all of which run through June 30, 2014, are multi-source awards. They include Hospira's general-purpose medication management technologies, such as the Plum A+(R) device; the next-generation Symbiq(R) infusion system with Hospira MedNet(R) safety software; and pain management pumps, such as the LifeCare PCA(R) device with Hospira MedNet(R) safety software, and GemStar(R) ambulatory devices. These products play a critical role in improving patient safety as well as enhancing quality of care and clinician workflow. Also covered within the agreements is access to contracts for Hospira's I.V. solutions, including the company's environmentally preferable VisIV(R) container, and the IV solutions' associated equipment portfolio.

"We are pleased to expand our relationship with Hospira," said Mark Miriani, president of MedAssets Supply Chain Systems. "Adding Hospira's full line of I.V. solutions and gr
'/>"/>